Metabolic profiling reveals potential metabolic markers associated with Hypoxia Inducible Factor-mediated signalling in hypoxic cancer cells
Open Access
- 28 October 2015
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 15649
Abstract
Hypoxia inducible factors (HIFs) plays an important role in oxygen compromised environments and therefore in tumour survival. In this research, metabolomics has been applied to study HIFs metabolic function in two cell models: mouse hepatocellular carcinoma and human colon carcinoma, whereby the metabolism has been profiled for a range of oxygen potentials. Wild type cells have been compared to cells deficient in HIF signalling to reveal its effect on cellular metabolism under normal oxygen conditions as well as low oxygen, hypoxic and anoxic environments. Characteristic responses to hypoxia that were conserved across both cell models involved the anti-correlation between 2-hydroxyglutarate, 2-oxoglutarate, fructose, hexadecanoic acid, hypotaurine, pyruvate and octadecenoic acid with 4-hydroxyproline, aspartate, cysteine, glutamine, lysine, malate and pyroglutamate. Further to this, network-based correlation analysis revealed HIF specific pathway responses to each oxygen condition that were also conserved between cell models. From this, 4-hydroxyproline was revealed as a regulating hub in low oxygen survival of WT cells while fructose appeared to be in HIF deficient cells. Pathways surrounding these hubs were built from the direct connections of correlated metabolites that look beyond traditional pathways in order to understand the mechanism of HIF response to low oxygen environments.Keywords
This publication has 34 references indexed in Scilit:
- Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of CancerCancer Cell, 2013
- A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylationGenome Research, 2012
- Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomasBMC Cancer, 2011
- Expression of hypoxia-inducible factor 1α in thyroid carcinomasEndocrine-Related Cancer, 2010
- Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cellsBritish Journal of Cancer, 2009
- Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in miceJournal of Clinical Investigation, 2008
- The Edinburgh human metabolic network reconstruction and its functional analysisMolecular Systems Biology, 2007
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylationThe EMBO Journal, 2001
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000